2026-02-04 02:33Investment Rating - The report rates the food and beverage industry as "essential consumption" with a stronger outlook than the market [2]. Core Insights - The Chinese food and beverage industry is transitioning from "incremental competition" to "stock competition," with overseas expansion becoming a crucial strategy for long-term survival and growth [6][12]. - The report identifies a four-stage model for overseas expansion, emphasizing the importance of supply chain specialization and ecological collaboration as the most promising path for Chinese companies [6][30]. Summary by Sections Four-Stage Overseas Expansion Model - The first stage is "Product Testing," focusing on low-cost market acceptance through exports [22]. - The second stage is "Localization," where companies establish local supply chains and operations to overcome trade barriers and enhance brand value [22]. - The third stage involves "Brand Acquisition and Integration," where companies pursue strategic acquisitions to expand their market presence [22]. - The fourth stage is "Global Value Network Construction," integrating global resources with regional agility to optimize efficiency and risk management [27]. Value Dimension Analysis - The report categorizes Chinese companies' overseas strategies into four types: efficiency advantage, product and category innovation, cultural empowerment and brand value, and supply chain ecological collaboration [30][31]. - Companies like Anqi Yeast and Xianle Health exemplify the supply chain specialization and ecological collaboration model, showcasing significant growth potential in overseas markets [30][47]. Growth Drivers and Recommended Targets - The report highlights that companies with established overseas operations and strong growth trajectories, such as Anqi Yeast and Xianle Health, are well-positioned for investment [47]. - Anqi Yeast has seen a compound annual growth rate of 20.7% in overseas revenue from 2022 to 2024, with a 37.6% share of total revenue coming from international markets [47][55]. - Xianle Health has achieved a remarkable 55.7% growth rate in overseas revenue during the same period, with 53.9% of its revenue derived from international operations [47][64].